Add Company
Join Now

Enlaza Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Enlaza Therapeutics's estimated annual revenue is currently $4.3M per year.(i)
  • Enlaza Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Enlaza Therapeutics has 55 Employees.(i)
  • Enlaza Therapeutics grew their employee count by 28% last year.

Enlaza Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Co-Founder, President and CBOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
VP, ChemistryReveal Email/Phone
5
VP- Research and TechnologyReveal Email/Phone
6
Head Lab OperationsReveal Email/Phone
7
SVP, CMC Product DevelopmentReveal Email/Phone
8
VP Research and TechnologyReveal Email/Phone
9
VP Pharmacology and Translational ResearchReveal Email/Phone
10
Associate DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Enlaza Therapeutics?

Enlaza Therapeutics is pioneering the field of covalent biologics.These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-LockTM platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$4.3M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.4M5541%N/A
#2
$13.4M554%N/A
#3
$7.2M55N/AN/A
#4
$7.2M55N/AN/A
#5
$6.9M55-10%$2M